학술논문
Determination of optimal dose and treatment schedule of the immunotherapeutic vaccine, DPX-Survivac, for combination immunotherapy treatment of ovarian, fallopian tube or peritoneal cancer (OC): A phase Ib study.
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755